Idorsia Competitors and Similar CompaniesClear all

Novartis's competitors and similar companies include Pfizer, Ipsen, Roche, Regeneron Pharmaceuticals, Vifor Pharma, Roivant Sciences and Biocon.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Ipsen
Ipsen
Ipsen SA is a France-based pharmaceutical company that produces a range of various types of drugs.
Roche
Roche
Roche Holding is a biotech company that provides in-vitro diagnostics and supplies solutions across various disease areas.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Vifor Pharma
Vifor Pharma
Vifor Pharma is a diversified group active throughout the healthcare market which, among other things, develops, manufactures, and markets pharmaceutical products.
Roivant Sciences
Roivant Sciences
Roivant Sciences is a company that develops and commercializes medicines.
Biocon
Biocon
Biocon is a global biopharmaceutical company.
Founding Date
Founding Date
1996
Founding Date
1849
Founding Date
1929
Founding Date
1896
Founding Date
1988
Founding Date
1927
Founding Date
2014
Founding Date
1978
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Basel, CH HQ
Tirana, AL
Buenos Aires, AR
Macquarie Park, AU
Kundl, AT
Unterlangkampfen, AT
Wien, AT
see more
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Bentley, AU
Footscray, AU
Mulgrave, AU
Sydney, AU
see more
Locations
Boulogne-Billancourt, FR HQ
Algiers, DZ
South Yarra, AU
Wien, AT
Merelbeke, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
North Ryde, AU
Sydney, AU
Wien, AT
Dhaka, BD
see more
Locations
Tarrytown, US HQ
Mississauga, CA
München, DE
Bengaluru, IN
Dublin, IE
Limerick, IE
Tokyo, JP
see more
Locations
Glattbrugg, CH HQ
Buenos Aires, AR
Melbourne, AU
Melbourne, AU
Wien, AT
Antwerpen, BE
São Paulo, BR
see more
Locations
London, GB HQ
Basel, CH
Boston, US
New York, US
Locations
Bengaluru, IN HQ
Bengaluru, IN
Hyderabad, IN
Visakhapatnam, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
see more
Employees
Employees
101,703
Employees
83,0005% increase
Employees
5,300
Employees
103,613
Employees
12,2563% increase
Employees
2,200
Employees
904
Employees
16,545
Valuation ($)
Valuation ($)
N/A
Valuation ($)
163.7 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
104.1 b
Valuation ($)
N/A
Valuation ($)
9.2 b
Valuation ($)
N/A
Twitter followers
Twitter followers
301.8 k
Twitter followers
491.8 k
Twitter followers
5.9 k
Twitter followers
247.2 k
Twitter followers
32.5 k
Twitter followers
N/A
Twitter followers
1.8 k
Twitter followers
21.8 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
16
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
33
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
16
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
8.5
Average likes per tweet (last 30 days)
63.4
Average likes per tweet (last 30 days)
2.4
Average likes per tweet (last 30 days)
9.8
Average likes per tweet (last 30 days)
4.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.3
Average likes per tweet (last 30 days)
4.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
84.85%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
83.33%
Percentage of tweets with engagement (last 30 days)
100%
Employee Rating
Employee Rating
4.2
Employee Rating
4.2
Employee Rating
4
Employee Rating
4.2
Employee Rating
4
Employee Rating
3
Employee Rating
3.6
Employee Rating
3.8

Financial

Revenue (est.)
Revenue (est.)
$54.1b (FY, 2023)
Revenue (est.)
$100.3b (FY, 2022)
Revenue (est.)
€3.2b (FY, 2022)
Revenue (est.)
CHF63.3b (FY, 2022)
Revenue (est.)
$13.1b (FY, 2023)
Revenue (est.)
CHF1.8b (FY, 2021)
Revenue (est.)
$61.3m (FY, 2023)
Revenue (est.)
₹109.3b (FY, 2023)
Cost of goods
Cost of goods
$8.2b (FY, 2023)
Cost of goods
$34.3b (FY, 2022)
Cost of goods
€423.6m (FY, 2022)
Cost of goods
CHF15.3b (FY, 2022)
Cost of goods
N/A
Cost of goods
CHF498.7m (FY, 2021)
Cost of goods
$131.3m (FY, 2023)
Cost of goods
₹39.3b (FY, 2023)
Gross profit
Gross profit
$47.7b (FY, 2023)
Gross profit
$66b (FY, 2022)
Gross profit
€2.9b (FY, 2022)
Gross profit
CHF51.1b (FY, 2022)
Gross profit
N/A
Gross profit
CHF1.3b (FY, 2021)
Gross profit
($70m) (FY, 2023)
Gross profit
₹78.5b (FY, 2023)
Net income
Net income
$9b (FY, 2023)
Net income
$31.4b (FY, 2022)
Net income
€603.1m (FY, 2022)
Net income
CHF13.5b (FY, 2022)
Net income
$4b (FY, 2023)
Net income
CHF265.4m (FY, 2021)
Net income
($1.1b) (FY, 2023)
Net income
₹6.4b (FY, 2023)

Operating

Patients
Patients
10 m (FY, 2022)
Patients
N/A
Patients
N/A
Patients
22.8 m (FY, 2023)
Patients
N/A
Patients
N/A
Patients
N/A
Patients
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
27 (FY, 2021)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
4 (Q2, 2021)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
25 (FY, 2021)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
5 (Q2, 2021)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
44 (FY, 2022)
Phase III Trials Products
27 (FY, 2021)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
1 (Q2, 2021)
Phase III Trials Products
N/A
Registration Phase Products
Registration Phase Products
8 (FY, 2022)
Registration Phase Products
10 (FY, 2021)
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
1 (Q2, 2021)
Registration Phase Products
N/A

Funding

Total funding raised
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 7.8b
Total funding raised
$ 53.9m
Total funding raised
N/A
Total funding raised
$ 1.9b
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Pfizer
HQ
New York, US
Employees
83,000↑ 5% increase

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.

View company
Ipsen
HQ
Boulogne-Billancourt, FR
Employees
5,300

Ipsen SA is a France-based pharmaceutical company that produces a range of various types of drugs.

View company
Roche
HQ
Basel, CH
Employees
103,613

Roche Holding is a biotech company that provides in-vitro diagnostics and supplies solutions across various disease areas.

View company
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
12,256↑ 3% increase

Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.

View company